Mridula Dilip, MD
@mdilip.bsky.social
Reposted by Mridula Dilip, MD
🌟 ABX Pearl of the Day: Duration of treatment in intra-abdominal infections (IAI)! 💊
💡 Q: How long should I treat IAI after source control?
🔍 A: While STOP-IT trial calls for 4 days post-source control, there are notable exceptions. See infographic for details 👇
#IDsky #AMSsky #MedSky #Pharmsky
💡 Q: How long should I treat IAI after source control?
🔍 A: While STOP-IT trial calls for 4 days post-source control, there are notable exceptions. See infographic for details 👇
#IDsky #AMSsky #MedSky #Pharmsky
November 22, 2024 at 6:07 PM
Reposted by Mridula Dilip, MD
#Medsky
jamanetwork.com/journals/jam...
In short:
Covid therapeutics decrease hospitalization, death (and, according to other pubs, long Covid). Their use is low (16.5%) for several reasons:
1. Patient choice
2. Inequity
3.possibly physician reluctance
4.drug drug interactions
Also 1/2
jamanetwork.com/journals/jam...
In short:
Covid therapeutics decrease hospitalization, death (and, according to other pubs, long Covid). Their use is low (16.5%) for several reasons:
1. Patient choice
2. Inequity
3.possibly physician reluctance
4.drug drug interactions
Also 1/2
COVID-19 Therapeutics for Nonhospitalized Older Adults
This Viewpoint summarizes the factors contributing to increased risk of severe outcomes and hospitalization associated with COVID-19 among older adults, stresses the importance of assessing COVID-19 r...
jamanetwork.com
November 22, 2024 at 12:51 PM
#Medsky
jamanetwork.com/journals/jam...
In short:
Covid therapeutics decrease hospitalization, death (and, according to other pubs, long Covid). Their use is low (16.5%) for several reasons:
1. Patient choice
2. Inequity
3.possibly physician reluctance
4.drug drug interactions
Also 1/2
jamanetwork.com/journals/jam...
In short:
Covid therapeutics decrease hospitalization, death (and, according to other pubs, long Covid). Their use is low (16.5%) for several reasons:
1. Patient choice
2. Inequity
3.possibly physician reluctance
4.drug drug interactions
Also 1/2